David A. Siegel Spruce Biosciences, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 13,800 shares of SPRB stock, worth $5,796. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,800
Previous 27,100
49.08%
Holding current value
$5,796
Previous $12,000
58.33%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SPRB
# of Institutions
32Shares Held
15.9MCall Options Held
0Put Options Held
0-
River Vest Venture Management LLC St. Louis, MO2.94MShares$1.23 Million20.39% of portfolio
-
Carlyle Group Inc. Washington, DC2.9MShares$1.22 Million1.19% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.61MShares$1.1 Million0.04% of portfolio
-
Abingworth LLP London, X01.79MShares$752,8570.65% of portfolio
-
Acadian Asset Management LLC Boston, MA1.05MShares$439,2470.0% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $9.9M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...